MedTrace Logo

Metformin Treatment in Adolescent Patients With PCOS: A Long-term, Winning Metabolic Choice.

NCT06015594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2023-08-29

No results posted yet for this study

Summary

This study aimed to understand whether metformin therapy can improve insulin resistance in adolescent PCOS patients, both during treatment and after discontinuation, and to evaluate its action on the hormonal and metabolic pathways.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Metformin

Patients treated with metformin

Sponsors & Collaborators

  • University of Cagliari

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-08-01
Completion
2022-05-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06015594 on ClinicalTrials.gov